Online ISSN: 2515-8260

Keywords : Corticosteroid injection

A Randomized Control Study of Comparison of Standard Care versusUltrasonography Guided Single Dose of MethylprednisoloneAcetate Injection for Planar Fasciopathy

Keshav Dev, Amar Singh Meena, Mahesh Meena, Mrinal Joshi

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 1344-1354

Objectives:Plantar fasciitis is a painful condition but can be self-limiting condition.
Among the different treatment which exit, physiotherapy and corticosteroid injection
are effective and popular. In this study, the author evaluated the efficacy of standard
care versus ultrasonography guided single dose of methylprednisolone acetate injection
for planar fasciopathy.
Design:This randomized clinical trial conducted in Physical Medicine & Rehabilitation
department of S M S medical college.
Method:Patients were allocated to standard care physiotherapy group (n=35) and
ultrasonography guided steroid injection group (n=35) equally. Pain and functional
ability on a visual analog scale (VAS), plantar fascia thickness and Foot Ankle
Disability Index (FADI) were evaluated at baseline and at 6 weeks after treatment.
Results:The mean age was not different between both groups (40.60±10.64 years versus
41.43±9.66 years, p=0.734). There was a reduction in VAS from baseline to weeks 6
(after treatment) (65.315±7.182 vs 32.57±4.235, respectively) (P<0.001). PF thickness at
6 weeks significantly reduced to 3.895±0.18 compared to baseline (P<0.001).FADI had a
considerable improved at week 6 (76.675±2.131) compared to baseline (62.915±1.823)
Conclusion:Both interventions caused improvement in pain and functional ability 2
months after treatment. Although inter difference were not significant.


Dr Sumit Pal Singh, Dr Pallav Gupta, Dr Nitish Sharma, Dr Anil Gupta, Dr Manmeet Singh

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 1620-1626

Aim:To compare the platelet-rich plasma therapy and corticosteroid injection in themanagement of planter fasciitis.
Methods: The prospective clinical trial was carried out at the Department of Orthopaedics. The research involved 40 patients who were randomly assigned to one of two groups: PRP (n=20) or Steroid (n=20). 25-27 ml of blood was taken from the cubital vein and deposited in a glass tube with 3 ml of citrate dextrose solution to make platelet-rich plasma (ratio 9:1). To avoid clotting, a citrate dextrose solution was utilised. For 10-13 minutes, the blood was centrifuged at 3300 rpm. The top buffy coat yielded 3ml of PRP preparation.
Results: In the steroid and PRP groups, the mean initial or pre injection VAS and AOFAS scores were 8.1±1.9, 60.37±9.58 and 8.9±2.6, 62.57±9.87, respectively, and were similar (0.15 and 0.22). Following injection, the score improved significantly in each group at each follow-up; however, no significant difference could be detected between the two groups at the 1 VAS (4.4±2.5 vs 3.5±0.88), AOFAS (79.89±9.74 vs 81.11±8.74), 3 VAS (2.6±0. 21 VS 2.1±0.78), AOFAS (84.15±10.55 VS 86.99±10.67) and 6-month VAS (2.1±0.85 VS 1.6±0.45, AOFA.
Conclusion: We found that steroid or PRP injection therapy for plantar fasciitis is equally effective.